| P2093 | author name string | Yan Fang | |
| | Qi Zhang | |
| | Rong Jiang | |
| | Shi Jin | |
| | Weiming Zhang | |
| | Zhaohui Ni | |
| | Chaojun Qi | |
| | Xinghua Shao | |
| | Mingli Zhu | |
| | Renhua Lu | |
| | Jiayi Yan | |
| | Haifen Zhang | |
| | Jiayue Lu | |
| P2860 | cites work | SOST is a target gene for PTH in bone | Q40411595 |
| | Pulse Wave Velocity: A Valuable Predictor for Cardio-Cerebrovascular Disease and Death in PD Patients | Q41423348 |
| | Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals | Q42717983 |
| | High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression | Q43272938 |
| | Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis? | Q44010748 |
| | Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level | Q44250442 |
| | Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. | Q46340775 |
| | Uremic toxicity and sclerostin in chronic kidney disease patients | Q49055431 |
| | Mineral metabolism, mortality, and morbidity in maintenance hemodialysis | Q50144395 |
| | Sclerostin: Another vascular calcification inhibitor? | Q50889523 |
| | Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. | Q51597110 |
| | Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. | Q52173037 |
| | Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients. | Q53339264 |
| | 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q55057254 |
| | Proteomics characterization of extracellular space components in the human aorta | Q24321762 |
| | Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis | Q28265821 |
| | Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? | Q33345061 |
| | The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells | Q33911294 |
| | High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. | Q34150412 |
| | Serum sclerostin is an independent predictor of mortality in hemodialysis patients | Q34695045 |
| | Sclerostin and Dickkopf-1 in renal osteodystrophy | Q34751932 |
| | Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study | Q35013412 |
| | Cardiovascular Mortality in End-Stage Renal Disease | Q35107192 |
| | Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. | Q35848843 |
| | FGF-23 and the progression of coronary arterial calcification in patients new to dialysis | Q36443208 |
| | Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification | Q37022989 |
| | Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice | Q37278407 |
| | Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans | Q37423382 |
| | Denosumab for treatment of postmenopausal osteoporosis | Q37904532 |
| | Arterial stiffness in chronic kidney disease: an update | Q38175796 |
| | The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women | Q39413639 |
| P433 | issue | 7 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 689-699 | |
| P577 | publication date | 2016-06-27 | |
| P1433 | published in | Biomarkers in Medicine | Q20313333 |
| P1476 | title | Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients. | |
| P478 | volume | 10 | |